In The Media

The future of medicine is here today!

 Dr. Yael Porat, CEO of BioGenCell (, describes the development of a groundbreaking technology for the automated production of personalized stem-cell therapies. These products, derived from the patient’s own blood, will be available on demand within 24 hours, to save lives and restore the quality of life for the billion people worldwide with blood vessel diseases including heart disease, stroke, PAD and dementia.

BioGenCell In the papers

As part of the Global Entrepreneurship Week, Dr Yael Porat,PHD was invited to speak about BioGencell’s stem cell therapy solution to lecture in front of the younger generation

Play Video
Dr. Yael Port in an interview with Prof. Carasso on Channel 10
Play Video
Development of a Stem Cell Therapy Product at Pace University's Entrepreneurship Lab
Play Video
The MIT Enterprise Forum in cooperation with Leon Recanati Graduate School of Business Administration

We'll be happy to hear from you!

Font Resize